Neoadjuvant toripalimab combined with chemotherapy in locally advanced HNSCC

Neoadjuvant toripalimab combined with chemotherapy in locally advanced HNSCC

IntroductionTo determine the safety and efficacy of neoadjuvant toripalimab combined with chemotherapy in locally advanced head and neck squamous cell carcinoma (LA-HNSCC).Patients and methodsThis single-arm investigator-initiated trial was conducted at a tertiary cancer hospital in China. The untre...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhaoyang Wang, Sheng Yang, Dangui Yan, Ye Zhang, Xiwei Zhang, Fa Zhang, Xiaohui Zhao, Zongmin Zhang, Shaoyan Liu, Lin Gui, Changming An
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Oncology
Subjects:
head and neck squamous cell carcinoma (HNSCC)
immunotherapy
neoadjuvant therapy
toripalimab
safety and efficacy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1571776/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2025.1571776/full

Similar Items